Join
Live feed
·
INSIDERFilingvia Quantisnow
Schrodinger Inc. logo

President of R&D, Therapeutics Akinsanya Karen was granted 15,625 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
SDGR· Schrodinger Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SDGR (Schrodinger Inc.) and more on Quantisnow.